Cipla’s South Africa-based subsidiary Cipla Medpro has announced its collaboration with Teva Pharmaceuticals Industries, the world’s largest generic pharmaceutical company.
Restricted to the territory of South Africa, the collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva’s broad pharmaceutical product portfolio, Cipla said in a filing to the BSE.
The focus areas are oncology, the central nervous system, women’s health, cardiovascular and ophthalmology, amongst other speciality products.
The collaboration is subject to the approval of the Competition Commission of South Africa.